Shelter Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Shelter Pharma	Bacil Pharma	ANG Lifesciences
Operational Metrics
Financials
5 yr Average ROE	15.08 %	-73.86 %	11.51 %
5yr average Equity Multiplier	1.38	1.72	3.24
5yr Average Asset Turnover Ratio	2.02	0.0	0.88
5yr Avg Net Profit Margin	7.29 %	0.0	1.44 %
Price to Book	0.0	2.01	0.77
P/E	7.05	46.2	0.0
5yr Avg Cash Conversion Cycle	151.86 Days	0.0	57.8 Days
Inventory Days	65.6 Days	0.0	76.41 Days
Days Receivable	77.72 Days	0.0	195.39 Days
Days Payable	5.04 Days	23.71 Days	179.71 Days
5yr Average Interest Coverage Ratio	71.95	-950.16	2.65
5yr Avg ROCE	21.3 %	-81.01 %	22.81 %
5yr Avg Operating Profit Margin	11.0 %	0.0	10.92 %
5 yr average Debt to Equity	0.04	0.08	0.87
5yr CAGR Net Profit	138.7 %	-28.45 %	n/a
5yr Average Return on Assets	11.22 %	-72.13 %	3.23 %
Shareholdings
Promoter Holding	52.32 %	0.2 %	70.6 %
Share Pledged by Promoters	0.0	0.0	44.88 %
Change in Promoter Holding (3 Yrs)	-4.57 %	-42.47 %	-0.55 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0